NCT02092558View on ClinicalTrials.gov

Evaluation of Immunological Disorders of T Lymphocytes and Endocrinological Disorders as Pathogen Factors in Patients With Metaplasia of Urinary Bladder

CompletedOBSERVATIONAL
Enrollment

2

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

January 31, 2009

Study Completion Date

December 31, 2013

Conditions
The Follow-up Duration Was 1-8 Years.The Main Reasons Behind Visiting the Hospital Were Recurrent Urinary Tract Infection,Urinary Urgencies, Pollakiuria, Difficulty in Initiating Micturition, Pain in Hypogastrium,Night Wetting and Day Wetting, Menstruation's Disorders, Urolithiasis, Defects of UrinarySystem and Hematuria.
Interventions
DRUG

Second-generation cephalosporin, nitrofurantoin, 1% aminoglycoside solution

DRUG

cephalosporin with chemotherapeutics

Second-generation cephalosporin was prescribed for 10 days, and then treatment crossover with chemotherapeutics in therapeutic dose (change in every week) during 3 months

Trial Locations (1)

05-092

Children's Hospital, Marii Konopnickiej Street 65, Dziekanów Lesny

All Listed Sponsors
lead

Children's Hospital, Dziekanów Leśny, Poland

OTHER

NCT02092558 - Evaluation of Immunological Disorders of T Lymphocytes and Endocrinological Disorders as Pathogen Factors in Patients With Metaplasia of Urinary Bladder | Biotech Hunter | Biotech Hunter